In February 2023, Chugai Pharma Taiwan (CPT), Board of Directors nominated Mr. Takashi Okamoto to become the new President of CPT, effective from 1st April 2023, due to the retirement of Mr. Henry Chen. The new President, Mr. Takashi Okamoto, is familiar with the healthcare industry and has extensive business experience. It's undeniable that under Okamoto's vision and leadership, CPT will continue to steadily achieve Chugai Group's goals, bring innovative products to patients, make contributions to society, and strive for the pinnacle of the industry, all while aiming to benefit human healthcare and wellbeing.
